ERBB2 and breast cancer: Moreover, the percentage of cells proliferating in these tumors was significantly lower than in Kras or Her2 tumors alone (Supplementary Fig. 6c, d), suggesting that in mammary tumors Plk1 overexpression results in increased CIN and growth inhibition.